Mucolytic therapy options of cough in children
L.S. Starostina
Sechenov University, Moscow
One of the most frequently prescribed drugs for the cough treatment in both adults and children are mucolytics, as they improve mucociliary clearance and facilitate the thick sputum removal from the tracheobronchial tree. Any ARI therapy requires a comprehensive treatment, including therapy with phytogenic drugs, taking into account all possible adverse events. The comprehensive treatment of patients with respiratory diseases (especially with chronic and recurrent inflammatory lung diseases) include drugs, reducing the sputum viscosity and elasticity, and improve expectoration. There is a great variety of drugs that have this action mechanism. In each case, the drug choice should be strictly individual, taking into account all the following possible factors: drug pharmacological action mechanism, pathological process nature, child age, possible formulation combinations. One of these drugs is a combined phytogenic drug Eucabal®, which is available in the form of emulsion and syrup.
Keywords: respiratory system, respiratory organs, cough, antitussives, mucolytics, secretolytic, cough in children, Eucabal.
For citation: Starostina L.S. et al. Mucolytic therapy options of cough in children. RMJ. Medical Review. 2019;3:64–70.
References
1. Статистическая информация. Минздрав России, 17 октября 2012. (Электронный ресурс). URL: https://www.rosminzdrav.ru/documents/6686 (дата обращения: 20.03.2019). [Statistical information Statistics, Ministry of health of Russia, October 17, 2012. (Electronic resource). URL: https://www.rosminzdrav.ru/documents/6686] https://eyepress.ru/article.aspx?20833 (access date: 20.03.2019) (in Russ.)].
2. Статистический сборник. 2017 год (Электронный ресурс). URL: https://nangs.org/analytics/rosstat-zdravookhranenie-v-rossii-s-prilozheniyami-onlajn-pdf-rar (дата обращения: 20.03.2019). [Statistical compendium 2017 (Electronic resource). URL: https://nangs.org/analytics/rosstat-zdravookhranenie-v-rossii-s-prilozheniyami-onlajn-pdf-rar (access date: 20.03.2019) (in Russ.)].
3. Dinh Q.T., Heck S., Le D.D. et al. Pathophysiology, Diagnostics and Therapy of Chronic Cough: Neuronal Reflexes and Antitussiva. Pneumol. 2013;67(6):327–334.
4. Haji A., Kimura S., Ohi Y. A model of the central regulatory system for cough reflex. Biol. Pharm. Bull. 2013;36(4):501–508.
5. Волков И.К. Кашель у детей. Причины и лечение. РМЖ. 2013;25:1218. [Volkov I.K. Cough in children. Causes and treatment. RMJ. 2013;25:1218 (in Russ.)].
6. Камалтынова Е.М. Муколитики в практике педиатра. Практика педиатра. 2011;2:47–51. [Kamaltynova E.M. Mucolytics in pediatric practice. Pediatrician practice. 2011;2:47–51 (in Russ.)].
7. Plevkova J., Song W.J. Chronic cough in subjects with upper airway diseases — analysis of mechanisms and clinical applications. Asia Pac. Allergy. 2013;3(2):127–135.
8. Venkatesh M., Rong L., Raad I., Versalovic J. Novel synergistic antibiofilm combinations for salvage of infected catheters. Journal of Medical Microbiology. 2009;58(7):936–944.
9. Naves P., Del Prado G., Huelves L. et al. Effects of human sierum albumium, ibuprofen and N-acetil-L-cysteine against biofilm formation by pathogenic Escheriachia Coli strains. Journal of Hospital Infection. 2010;76:165–170.
10. Батагов С.Я. Ацетилцистеин в лечении инфекций нижних дыхательных путей у взрослых. Лечащий врач. 2014;10:68–71. [Batagov S.Ya. Acetylcysteine in the treatment of lower respiratory tract infections in adults. Treating physician. 2014;10:68–71 (in Russ.)].
11. Зайцева О.В. Рациональный выбор муколитической терапии в лечении болезней органов дыхания у детей. РМЖ. 2010;17(18):1–6. [Zaytseva O.V. Rational choice of mucolytic therapy in the treatment of respiratory diseases in children. RMJ. 2010;17(18):1–6 (in Russ.)].
12. Мизерницкий Ю.Л., Ермакова И.Н. Современные мукоактивные препараты в терапии острых респираторных заболеваний у детей. Педиатрия. 2007;9(1):53–56 [Myzernitsky Ju.L., Ermakova I.N. Modern mucoactive drugs in the treatment of acute respiratory diseases in children. Pediatrics. 2007;9(1):53–56 (in Russ.)].
13. Влажный кашель. Гид по мукоактивным средствам. Справочник провизора. 2012 (Электронный ресурс). URL: http://con-med.ru/magazines/pharmacist/pharmacist-04–2012/vlazhnyy_kashel_gid_po_mukoaktivnym_sredstvam (дата обращения: 20.03.2019). [Productive cough. Guide to mucoactive agents. Handbook of the pharmacist, 2012 (Electronic resource). URL: http://con-med.ru/magazines/pharmacist/pharmacist-04–2012/vlazhnyy_kashel_gid_po_mukoaktivnym_sredstvam (access date: 20.03.2019) (in Russ.)].
14. Гончарова О.В., Камелденова Д.Б., Потапов В.Н. и др. Медикаментозные и немедикаментозные методы реабилитации детей с респираторными инфекциями. РМЖ. 2018;10(II):84–91. [Goncharova O.V., Kameldenova D.B., Potapov V.N. et al. Medical and non-drug methods of rehabilitation of children with respiratory infections. RMJ. 2018;10(II):84–91 (in Russ.)].
15. Государственный реестр лекарственных средств. Официальное издание: в 2 тт. М.: Медицинский совет, 2009. [State register of medicinal products. Official publication: in 2 tt. M.: Medical Council, 2009 (in Russ.)].
16. Реестр лекарственных средств России (Электронный ресурс). URL: https://www.rlsnet.ru/books_book_id_2_page_145.htm (дата обращения: 20.03.2019). [Register of medicines of Russia (Electronic resource). URL: https://www.rlsnet.ru/books_book_id_2_page_145.htm (access date: 20.03.2019) (in Russ.)].
2. Статистический сборник. 2017 год (Электронный ресурс). URL: https://nangs.org/analytics/rosstat-zdravookhranenie-v-rossii-s-prilozheniyami-onlajn-pdf-rar (дата обращения: 20.03.2019). [Statistical compendium 2017 (Electronic resource). URL: https://nangs.org/analytics/rosstat-zdravookhranenie-v-rossii-s-prilozheniyami-onlajn-pdf-rar (access date: 20.03.2019) (in Russ.)].
3. Dinh Q.T., Heck S., Le D.D. et al. Pathophysiology, Diagnostics and Therapy of Chronic Cough: Neuronal Reflexes and Antitussiva. Pneumol. 2013;67(6):327–334.
4. Haji A., Kimura S., Ohi Y. A model of the central regulatory system for cough reflex. Biol. Pharm. Bull. 2013;36(4):501–508.
5. Волков И.К. Кашель у детей. Причины и лечение. РМЖ. 2013;25:1218. [Volkov I.K. Cough in children. Causes and treatment. RMJ. 2013;25:1218 (in Russ.)].
6. Камалтынова Е.М. Муколитики в практике педиатра. Практика педиатра. 2011;2:47–51. [Kamaltynova E.M. Mucolytics in pediatric practice. Pediatrician practice. 2011;2:47–51 (in Russ.)].
7. Plevkova J., Song W.J. Chronic cough in subjects with upper airway diseases — analysis of mechanisms and clinical applications. Asia Pac. Allergy. 2013;3(2):127–135.
8. Venkatesh M., Rong L., Raad I., Versalovic J. Novel synergistic antibiofilm combinations for salvage of infected catheters. Journal of Medical Microbiology. 2009;58(7):936–944.
9. Naves P., Del Prado G., Huelves L. et al. Effects of human sierum albumium, ibuprofen and N-acetil-L-cysteine against biofilm formation by pathogenic Escheriachia Coli strains. Journal of Hospital Infection. 2010;76:165–170.
10. Батагов С.Я. Ацетилцистеин в лечении инфекций нижних дыхательных путей у взрослых. Лечащий врач. 2014;10:68–71. [Batagov S.Ya. Acetylcysteine in the treatment of lower respiratory tract infections in adults. Treating physician. 2014;10:68–71 (in Russ.)].
11. Зайцева О.В. Рациональный выбор муколитической терапии в лечении болезней органов дыхания у детей. РМЖ. 2010;17(18):1–6. [Zaytseva O.V. Rational choice of mucolytic therapy in the treatment of respiratory diseases in children. RMJ. 2010;17(18):1–6 (in Russ.)].
12. Мизерницкий Ю.Л., Ермакова И.Н. Современные мукоактивные препараты в терапии острых респираторных заболеваний у детей. Педиатрия. 2007;9(1):53–56 [Myzernitsky Ju.L., Ermakova I.N. Modern mucoactive drugs in the treatment of acute respiratory diseases in children. Pediatrics. 2007;9(1):53–56 (in Russ.)].
13. Влажный кашель. Гид по мукоактивным средствам. Справочник провизора. 2012 (Электронный ресурс). URL: http://con-med.ru/magazines/pharmacist/pharmacist-04–2012/vlazhnyy_kashel_gid_po_mukoaktivnym_sredstvam (дата обращения: 20.03.2019). [Productive cough. Guide to mucoactive agents. Handbook of the pharmacist, 2012 (Electronic resource). URL: http://con-med.ru/magazines/pharmacist/pharmacist-04–2012/vlazhnyy_kashel_gid_po_mukoaktivnym_sredstvam (access date: 20.03.2019) (in Russ.)].
14. Гончарова О.В., Камелденова Д.Б., Потапов В.Н. и др. Медикаментозные и немедикаментозные методы реабилитации детей с респираторными инфекциями. РМЖ. 2018;10(II):84–91. [Goncharova O.V., Kameldenova D.B., Potapov V.N. et al. Medical and non-drug methods of rehabilitation of children with respiratory infections. RMJ. 2018;10(II):84–91 (in Russ.)].
15. Государственный реестр лекарственных средств. Официальное издание: в 2 тт. М.: Медицинский совет, 2009. [State register of medicinal products. Official publication: in 2 tt. M.: Medical Council, 2009 (in Russ.)].
16. Реестр лекарственных средств России (Электронный ресурс). URL: https://www.rlsnet.ru/books_book_id_2_page_145.htm (дата обращения: 20.03.2019). [Register of medicines of Russia (Electronic resource). URL: https://www.rlsnet.ru/books_book_id_2_page_145.htm (access date: 20.03.2019) (in Russ.)].
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article
Распечатать